{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:27:11Z","timestamp":1791894431687,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.cancergen.2019.04.063","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T11:41:32Z","timestamp":1556106092000},"page":"72-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Uptake of genetic testing for germline BRCA1\/2 pathogenic variants in a predominantly Hispanic population"],"prefix":"10.1016","volume":"235-236","author":[{"given":"Julia E.","family":"McGuinness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghna S.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Awilda","family":"Marte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Kukafka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine D.","family":"Crew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2019.04.063_bib0001","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0002","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0003","first-page":"840","article-title":"Uptake rates for breast cancer genetic testing: a systematic review","volume":"15","author":"Ropka","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0004","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/ejhg.2014.180","article-title":"A systematic review of factors that act as barriers to patient referral to genetic services","volume":"23","author":"Delikurt","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/tbj.12736","article-title":"Population-based study of attitudes toward BRCA genetic testing among orthodox Jewish women","volume":"23","author":"Tang","year":"2017","journal-title":"Breast J"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0006","first-page":"799","article-title":"Coherence and completeness of population-based family cancer reports","volume":"19","author":"Wideroff","year":"2010","journal-title":"Cancer Epidemiol Biomark Prev A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0007","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jnci\/djr114","article-title":"Confirmation of family cancer history reported in a population-based survey","volume":"103","author":"Mai","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0008","first-page":"174","article-title":"The comprehensiveness of family cancer history assessments in primary care","volume":"10","author":"Murff","year":"2007","journal-title":"Community Genet"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0009","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1200\/JCO.2013.51.4661","article-title":"Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative","volume":"32","author":"Wood","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0010","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s11606-014-3113-5","article-title":"Impact of a randomized controlled educational trial to improve physician practice behaviors around screening for inherited breast cancer","volume":"30","author":"Bell","year":"2015","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0011","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10549-015-3374-7","article-title":"Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer","volume":"151","author":"Cragun","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0012","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/GIM.0b013e3182091ba4","article-title":"Underutilization of BRCA1\/2 testing to guide breast cancer treatment: black and Hispanic women particularly at risk","volume":"13","author":"Levy","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0013","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.293.14.1729","article-title":"Racial differences in the use of BRCA1\/2 testing among women with a family history of breast or ovarian cancer","volume":"293","author":"Armstrong","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0014","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/GIM.0b013e3181c9af2d","article-title":"Exploring attitudes, beliefs, and communication preferences of Latino community members regarding BRCA1\/2 mutation testing and preventive strategies","volume":"12","author":"Kinney","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0015","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1186\/s12889-017-4375-8","article-title":"Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review","volume":"17","author":"Hann","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0016","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/cncr.23173","article-title":"Family history of cancer: is it an accurate indicator of cancer risk in the immigrant population?","volume":"112","author":"Orom","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0017","first-page":"746","article-title":"Perceived cancer risk: why is it lower among nonwhites than whites?","volume":"19","author":"Orom","year":"2010","journal-title":"Cancer Epidemiol Biomark Prev A Publication Of The American Association For Cancer Research, Cosponsored By The American Society Of Preventive Oncology"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0018","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12687-015-0257-x","article-title":"Participation of low-income women in genetic cancer risk assessment and BRCA 1\/2 testing: the experience of a safety-net institution","volume":"7","author":"Komenaka","year":"2016","journal-title":"J Community Genet"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0019","first-page":"446","article-title":"Factors associated with false positive results on screening mammography in a population of predominantly Hispanic women","volume":"27","author":"McGuinness","year":"2018","journal-title":"Cancer Epidemiol Biomark Prev A Publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0020","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","article-title":"Projecting individualized probabilities of developing breast cancer for white females who are being examined annually","volume":"81","author":"Gail","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0021","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000336419","article-title":"Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach","volume":"15","author":"Joseph","year":"2012","journal-title":"Public Health Genom"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0022","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000452095","article-title":"Validation of an efficient screening tool to identify low-income women at high risk for hereditary breast cancer","volume":"19","author":"Stewart","year":"2016","journal-title":"Public Health Genom"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0023","doi-asserted-by":"crossref","first-page":"e13044","DOI":"10.1200\/JCO.2017.35.15_suppl.e13044","article-title":"Identifying women at high-risk for breast cancer using data from the electronic health record compared to self-report","volume":"35","author":"Li","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0024","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.pec.2013.04.008","article-title":"Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool","volume":"92","author":"Rupert","year":"2013","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10549-016-3726-y","article-title":"iPrevent(R): a tailored, web-based, decision support tool for breast cancer risk assessment and management","volume":"156","author":"Collins","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0026","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/cncr.22202","article-title":"Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening","volume":"107","author":"Hoskins","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0027","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pec.2007.04.001","article-title":"Online patient education and risk assessment: project OPERA from Cancerbackup. Putting inherited breast cancer risk information into context using argumentation theory","volume":"67","author":"Mackay","year":"2007","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0028","doi-asserted-by":"crossref","unstructured":"McAlpine K, Lewis KB, Trevena LJ, Stacey D. What Is the effectiveness of patient decision aids for cancer-related decisions? A systematic review subanalysis. JCO Clin Cancer Inf2018:1\u201313.","DOI":"10.1200\/CCI.17.00148"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0029","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1186\/s12913-018-3442-x","article-title":"Study protocol: a cluster randomized controlled trial of web-based decision support tools for increasing BRCA1\/2 genetic counseling referral in primary care","volume":"18","author":"Silverman","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0030","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1200\/JCO.18.01631","article-title":"Underdiagnosis of hereditary breast cancer: are genetic testing guidelines a tool or an obstacle?","volume":"37","author":"Beitsch","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cancergen.2019.04.063_bib0031","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/jnci\/djx265","article-title":"Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women","volume":"110","author":"Manchanda","year":"2018","journal-title":"J Natl Cancer Inst"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776219300596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776219300596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:43:28Z","timestamp":1761896608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776219300596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":31,"alternative-id":["S2210776219300596"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2019.04.063","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uptake of genetic testing for germline BRCA1\/2 pathogenic variants in a predominantly Hispanic population","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2019.04.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}